Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
These effects typically diminish within 24 weeks as your body adapts
Prevalence of autism spectrum disorder among children aged 8 yearsautism and developmental disabilities monitoring network, 11 sites, United States, 2010
FDA approval and indications Tirzepatide was first approved by the FDA in May 2022 as Mounjaro, a once-weekly injectable medication for the treatment of adults with type 2 diabetes
Recommendation: Good candidate for split dosing, especially during dose escalation
US$ 22.85
US$ 27.84
US$ 28.42
US$ 22.10
US$ 23.49
US$ 27.62
US$ 24.04
